These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Branch retinal vein occlusion during fingolimod treatment in a patient with multiple sclerosis. Gallego-Pinazo R; España-Gregori E; Casanova B; Pardo-López D; Díaz-Llopis M J Neuroophthalmol; 2011 Sep; 31(3):292-3. PubMed ID: 21826025 [No Abstract] [Full Text] [Related]
7. [A plan for risk management in the treatment of multiple sclerosis with gilenia (fingolimod)]. Popova NF Zh Nevrol Psikhiatr Im S S Korsakova; 2011; 111(2 Pt 2):110-3. PubMed ID: 21916166 [No Abstract] [Full Text] [Related]
8. Multiple sclerosis rebound following herpes zoster infection and suspension of fingolimod. Gross CM; Baumgartner A; Rauer S; Stich O Neurology; 2012 Nov; 79(19):2006-7. PubMed ID: 23035074 [No Abstract] [Full Text] [Related]
9. Cystoid macular edema associated with fingolimod use for multiple sclerosis. Afshar AR; Fernandes JK; Patel RD; Ksiazek SM; Sheth VS; Reder AT; Hariprasad SM JAMA Ophthalmol; 2013 Jan; 131(1):103-7. PubMed ID: 23307220 [No Abstract] [Full Text] [Related]
10. Delayed fingolimod-associated asystole. Espinosa PS; Berger JR Mult Scler; 2011 Nov; 17(11):1387-9. PubMed ID: 21652609 [TBL] [Abstract][Full Text] [Related]
11. Oral fingolimod (gilenya) for multiple sclerosis. Med Lett Drugs Ther; 2010 Dec; 52(1353-1354):98-9. PubMed ID: 21344782 [No Abstract] [Full Text] [Related]
13. [New, effective immunomodulatory drug in treatment of multiple sclerosis: the fingolimod]. Komoly S Ideggyogy Sz; 2012 Nov; 65(11-12):421-2. PubMed ID: 23289178 [No Abstract] [Full Text] [Related]
14. Kaposi sarcoma in a patient with relapsing-remitting multiple sclerosis receiving fingolimod. Tully T; Barkley A; Silber E Neurology; 2015 May; 84(19):1999-2001. PubMed ID: 25878178 [No Abstract] [Full Text] [Related]
15. A patient with Leiden V mutation, multiple sclerosis, psoriasis, and sicca syndrome: could celecoxib and fingolimod adversely affect the heart? Cocco G Cardiovasc Toxicol; 2012 Sep; 12(3):266-72. PubMed ID: 22528818 [TBL] [Abstract][Full Text] [Related]
16. [Cystoid macular oedema after fingolimod treatment in multiple sclerosis]. Asensio-Sánchez VM; Trujillo-Guzmán L; Ramoa-Osorio R Arch Soc Esp Oftalmol; 2014 Mar; 89(3):104-6. PubMed ID: 24269406 [TBL] [Abstract][Full Text] [Related]
17. Prolonged and symptomatic bradycardia following a single dose of fingolimod. Faber H; Fischer HJ; Weber F Mult Scler; 2013 Jan; 19(1):126-8. PubMed ID: 22729989 [TBL] [Abstract][Full Text] [Related]
19. Oral fingolimod to treat multiple sclerosis: see your cardiologist first. Sato DK; Callegaro D Arq Neuropsiquiatr; 2014 Sep; 72(9):651-2. PubMed ID: 25252227 [No Abstract] [Full Text] [Related]
20. Fingolimod-associated amenorrhea: a report of three cases. Alroughani R Mult Scler; 2014 Oct; 20(12):1662-4. PubMed ID: 24515730 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]